Stay updated on Tolebrutinib in NRSPMS Clinical Trial

Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice appears at the top of the page announcing NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:56:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:43:24.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-10T14:47:34.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now renders a 403 error instead of the study record content, making the trial information inaccessible on this page.
    Difference
    17%
    Check dated 2026-09-19T19:33:16.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Israel study locations were updated: the Qiryat Krinitzi site (52621) was removed and the Tel Litwinsky site (52621) was added, affecting enrollment options in the region.
    Difference
    0.1%
    Check dated 2026-09-12T18:34:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Qiryat Krinitzi, Israel, 52621 as a new study site. Removed Tel Litwinsky, Israel, 52621 from the site list.
    Difference
    0.1%
    Check dated 2026-09-05T20:49:22.000Z thumbnail image

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.